Literature DB >> 2270485

Zinc mediation of the binding of human growth hormone to the human prolactin receptor.

B C Cunningham1, S Bass, G Fuh, J A Wells.   

Abstract

Human growth hormone (hGH) elicits a diverse set of biological activities including lactation that derives from binding to the prolactin (PRL) receptor. The binding affinity of hGH for the extracellular binding domain of the hPRL receptor (hPRLbp) was increased about 8000-fold by addition of 50 micromolar ZnCl2. Zinc was not required for binding of hGH to the hGH binding protein (hGHbp) or for binding of hPRL to the hPRLbp. Other divalent metal ions (Ca2+, Mg2+, Cu2+, Mn2+, and Co2+) at physiological concentrations did not support such strong binding. Scatchard analysis indicated a stoichiometry of one Zn2+ per hGH.hPRLbp complex. Mutational analysis showed that a cluster of three residues (His18, His21, and Glu174) in hGH and His188 from the hPRLbp (conserved in all PRL receptors but not GH receptors) are probable Zn2+ ligands. This polypeptide hormone.receptor "zinc sandwich" provides a molecular mechanism to explain why nonprimate GHs are not lactogenic and offers a molecular link between zinc deficiency and its association with altered functions of hGH.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2270485     DOI: 10.1126/science.2270485

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  58 in total

1.  Sustained release of human growth hormone from PLGA solution depots.

Authors:  K J Brodbeck; S Pushpala; A J McHugh
Journal:  Pharm Res       Date:  1999-12       Impact factor: 4.200

2.  Zinc binding to human lactogenic hormones and the human prolactin receptor.

Authors:  Jeffrey L Voorhees; Geeta Vittal Rao; Timothy J Gordon; Charles L Brooks
Journal:  FEBS Lett       Date:  2011-04-15       Impact factor: 4.124

Review 3.  Molecular heterogeneity of human GH: from basic research to clinical implications.

Authors:  C L Boguszewski
Journal:  J Endocrinol Invest       Date:  2003-03       Impact factor: 4.256

4.  Direct zinc binding to purified rhodopsin and disc membranes.

Authors:  T A Shuster; A K Nagy; D C Conly; D B Farber
Journal:  Biochem J       Date:  1992-02-15       Impact factor: 3.857

5.  Obligate ordered binding of human lactogenic cytokines.

Authors:  Jeffery L Voorhees; Charles L Brooks
Journal:  J Biol Chem       Date:  2010-04-28       Impact factor: 5.157

6.  Zinc induces dimerization of the class II major histocompatibility complex molecule that leads to cooperative binding to a superantigen.

Authors:  Hongmin Li; Yiwei Zhao; Yi Guo; Zhong Li; Leslie Eisele; Walid Mourad
Journal:  J Biol Chem       Date:  2006-12-13       Impact factor: 5.157

7.  Growth hormone (GH) receptor (GHR)-specific inhibition of GH-Induced signaling by soluble IGF-1 receptor (sol IGF-1R).

Authors:  Yue Zhang; Sajina Gc; Sweta B Patel; Ying Liu; Andrew J Paterson; John C Kappes; Jing Jiang; Stuart J Frank
Journal:  Mol Cell Endocrinol       Date:  2019-05-14       Impact factor: 4.102

8.  A quantitative model of thermal stabilization and destabilization of proteins by ligands.

Authors:  Piotras Cimmperman; Lina Baranauskiene; Simona Jachimoviciūte; Jelena Jachno; Jolanta Torresan; Vilma Michailoviene; Jurgita Matuliene; Jolanta Sereikaite; Vladas Bumelis; Daumantas Matulis
Journal:  Biophys J       Date:  2008-07-03       Impact factor: 4.033

9.  Autocrine human growth hormone stimulates oncogenicity of endometrial carcinoma cells.

Authors:  Vijay Pandey; Jo K Perry; Kumarasamypet M Mohankumar; Xiang-Jun Kong; Shu-Min Liu; Zheng-Sheng Wu; Murray D Mitchell; Tao Zhu; Peter E Lobie
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

10.  Evaluation of growth hormone bioactivity using the Nb2 cell bioassay in children with growth disorders.

Authors:  M Bozzola; M Zecca; F Locatelli; G Radetti; S Pagani; M Autelli; L Tatò; P Chatelain
Journal:  J Endocrinol Invest       Date:  1998-12       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.